Carl Anthony Osborne, seeCOLe, LLC Founder and CEO: “What sets us apart is our focus on workflow integration and clinical usability. While many companies are building powerful AI models, we’re focused on how those capabilities actually fit into a clinician’s day.”

seeCOLe, LLC is a healthcare technology company founded in 2019 by Carl Anthony Osborne, a clinical informatics expert driven by a clear mission: to redesign how clinicians interact with digital systems. Headquartered across Sunrise, Florida; Middletown, Delaware; and Portland, Oregon, the company focuses on serving hospitals, health systems, clinicians, and healthcare IT leaders who are seeking more intuitive and efficient ways to access and use patient data. The idea behind seeCOLe emerged from Osborne’s firsthand experience in clinical environments, where he observed a persistent disconnect between healthcare providers and the tools meant to support them. Electronic health records, while essential, often required clinicians to shift their attention away from patients and toward screens. Recognizing this gap, seeCOLe was built to reverse that dynamic by making technology adapt to clinicians, not the other way around.

At its core, seeCOLe develops augmented reality solutions that bring patient data directly into a clinician’s natural field of vision through smart glasses. These tools integrate seamlessly with major electronic health record systems such as Oracle Cerner and Epic, allowing hands-free interaction with critical information. Complementing this is MARY, an AI-powered mobile assistant designed to help clinicians quickly retrieve, summarize, and navigate patient data using natural language. Together, these technologies create a connected ecosystem that supports clinicians wherever they are—at the bedside, moving between departments, or working remotely. By reducing friction in clinical workflows, seeCOLe enables healthcare professionals to stay focused on what matters most: delivering high-quality patient care.

With early-stage pilots and partnerships, including collaborations with InterSystems and a pilot agreement with Assuta Medical Center in Israel, seeCOLe continues to position itself at the forefront of innovation in digital health.

In conversation with Carl Anthony Osborne, Founder and CEO of seeCOLe, LLC

2026 is a pivotal year for healthtech. What momentum or milestones has seeCOLe achieved recently that position you as a company to watch this year?

2026 has already been transformative for us. Our partnership with InterSystems has been a major milestone, giving us access to a robust, scalable data platform through IRIS and accelerating our ability to integrate across healthcare systems. We’ve successfully demonstrated MARY in live environments, including major industry events, where clinicians could interact with real patient scenarios in real time. Additionally, winning “Most Innovative” recognition again at InterSystems READY reinforced that what we’re building isn’t just visionary—it’s practical, scalable, and needed now.

Your AI assistant MARY addresses clinician burnout from EHR documentation. How is MARY evolving, and what feedback are you hearing?

MARY is evolving from a query-based assistant into a true clinical co-pilot. We’re enhancing its ability to understand context, anticipate clinician needs, and deliver concise, relevant insights without requiring extensive navigation. The feedback has been powerful—clinicians consistently tell us that MARY feels like “having a knowledgeable assistant at your side.” What stands out most is how quickly users shift from curiosity to reliance. They start by asking simple questions, but soon they’re using MARY to guide decision-making, retrieve histories, and reduce time spent searching through charts.

What has been the most surprising insight from watching clinicians interact with AR for the first time?

The most surprising—and impactful—moment is how quickly clinicians trust the experience. Within minutes, they stop thinking about the technology and start focusing on the patient. There’s a visible shift: less screen-switching, more eye contact, and more fluid interactions. Many clinicians say it feels like “medicine without barriers.” That moment validates everything—we’re not just improving workflows, we’re restoring the human connection in care.

How do you envision AR bridging the gap between in-person and virtual care in the next 12–18 months?

AR has the potential to become the connective tissue between physical and virtual care. In the near term, we see clinicians using AR to collaborate remotely—sharing real-time views, annotations, and patient data during consultations. Imagine a specialist guiding a bedside clinician from across the country, seeing exactly what they see. Over the next 12–18 months, AR will make telemedicine more immersive, more precise and more collaborative — bringing expertise to the point of care regardless of location.

With major players investing in medical AI, what differentiates seeCOLe’s approach?

What sets us apart is our focus on workflow integration and clinical usability. While many companies are building powerful AI models, we’re focused on how those capabilities actually fit into a clinician’s day. Our use of FHIR APIs ensures interoperability across systems, and our cloud-native architecture—strengthened through InterSystems—allows us to scale securely and efficiently. But most importantly, we’re not asking clinicians to change how they work—we’re embedding intelligence directly into their existing workflows, making adoption natural and immediate.

Which emerging application excites you most for improving patient outcomes this year?

One area I’m especially excited about is medication management in pharmacy and inpatient settings. With AR and MARY combined, clinicians can verify medications, review contraindications, and access critical patient data instantly—without breaking workflow. This has a direct impact on patient safety and outcomes. Reducing errors while increasing efficiency is a powerful combination, and we’re already seeing how this can transform care delivery.

What does the future hold for your company and its customers?

The future is incredibly exciting. We’re expanding both our AR capabilities and MARY’s intelligence, while deepening our integrations with leading health systems. Our roadmap includes broader deployment across North America, enhanced remote collaboration features, and more predictive capabilities within MARY. For our customers, this means a more connected, efficient, and intelligent healthcare environment—where technology truly works for them, not against them.

Meet the leader behind the success of seeCOLe, LLC

Carl Anthony Osborne, Founder and CEO

Carl Anthony Osborne is a healthcare IT innovator with over 16 years of experience in clinical informatics and digital transformation. As the founder of seeCOLe, he has led the development of cutting-edge solutions that merge augmented reality and AI to improve how clinicians interact with data. His work is driven by a simple but powerful vision: to restore the human connection in healthcare by removing the barriers created by technology. Through partnerships like InterSystems and continued innovation, he is helping shape the future of care delivery.

“AR has the potential to become the connective tissue between physical and virtual care. In the near term, we see clinicians using AR to collaborate remotely—sharing real-time views, annotations, and patient data during consultations.”